Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Metabolic syndrome is associated with increased cancer risk and progression at almost all sites, including the prostate in high-stage prostate cancer, but several reports have described an inverse relationship between metabolic syndrome and its components and low-stage incident prostate cancer. Here, Hammarsten et al. hypothesize that the inverse link between metabolic syndrome and its components and low-stage incident prostate cancer might simply be the result of bias mechanisms.
